Palvella Therapeutics (PVLA) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Palvella Therapeutics (PVLA) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Palvella Therapeutics

· PVLA

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

2.003 B

-3.77%

General

Market Cap: $2B
Enterprise Value: $1.72B
Shares Outstanding: 14,340,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -24.34%
ROE: -47.84%
ROIC: -23.88%
Current Ratio: 21.18
Debt-to-Equity: 0.00
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 8.78
EV/EBITDA: -34.33

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $57.74M
Operating Income: -$57.74M
Net Profit: -$61.7M

Balance Sheet

Cash and Equivalents: $187.8M
Working Capital: $241.08M
Total Assets: $253.51M
Net Debt: -$187.27M
Total Liabilities: $36.58M
Total Equity: $216.87M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$36.51M
Cash Flow from Investing: -$62.47M
Cash Flow from Financing: $216.2M
Free Cash Flow: -$36.51M
Capital Expenditures: $0